4DMT shoots for a $75M IPO, its second attempt to go public with its gene therapy vector programs
Pfizer prepares to file COVID-19 shot after reaching safety milestone
Sanofi Wins FDA Priority Review For Enzyme Therapy; Street Bullish
U.S. hospitals to restrict Lilly Covid-19 antibody treatment due to limited supply
Promising results from in vitro combination therapy against COVID-19
Coronavirus treatments: keep your eye on anti-complement drugs – they look promising
Fresh doubts over BMS’ merger payout as FDA delays key drug review
Why COVID-19 Testing Is A Tragic Waste
FDA delays decision on Bristol Myers cancer therapy due to Covid-19 travel curbs
What monoclonal antibodies are – and why we need them as well as a vaccine
Roche’s Herceptin/Perjeta combo product nears EU approval
Guido Rasi steps down, handing the running of EMA to Emer Cooke
FDA Approves Keytruda for Triple‑Negative Breast Cancer
How Effective Will Lilly’s Bamlanivimab be in the Battle Against Covid-19?
Doubling down on Sanofi's French roots, Paul Hudson infuses €50M into Jeito Capital to boost homegrown biotechs
Janssen combines Darzalex with COVID drug in new multiple myeloma submission
Treatments for people with early COVID-19 infection is an urgent research focus
Is Five Prime Stock a Buy Right Now? This Is What You Need To Know
Exclusive: WHO-led Covid drug scheme doubles down on antibodies, steroids and shuns remdesivir
US Coronavirus Risk Is Rising
Domestic abuse and mental ill-health: twin shadow pandemics stalk the second wave
US COVID-19 Hospitalizations Match April Highs As US Tops 100k Cases For 6th Day: Live Updates
Global Rally Fizzles, Nasdaq Tumbles As Pfizer Vaccine Skepticism Emerges
Lilly to ship COVID-19 drug straight away after FDA green light
Eli Lilly’s Covid-19 Antibody Treatment Gets FDA Emergency Use Nod
After NICE okay, Scots denied access to Vifor’s Veltassa
U.S. allows emergency use of first Covid-19 antibody drug
Could SARS-CoV-2 evolve resistance to COVID-19 vaccines?
$1 million to support manufacturing of COVID-19 treatments, vaccines at uOttawa, Ottawa Hospital
Digital therapies for opioid use disorder need more data, says ICER